Follow the Panacea Biotec Limited share price and the full directors' dealings record of the company, a listed equity based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Panacea Biotec Limited has logged 43 public disclosures. Market capitalisation: €25.8bn. The latest transaction was filed on 1 October 2025 (Purchase). Among the most active insiders: Sandeep Jain. Every trade is free.
43
Insider Decl.
n/a
Thresholds
€27,091
6 ops.
Buy Volume
€2m
37 ops.
Sell Volume
18Σ signal
Buys €27,091€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,091 of 29,063 companies
44.4
score / 100
Value
32
Quality
57
FCF yld-1.4%
Earn yld-0.2%
EV/EBITDA·
ROE·
Gross mgn56%
Net mgn-0.8%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
123,865 shares@ ₹266.799216.2% of flowEquity SharesSEBI:dcca48c60e9141c2f5112d44cbf2119ebe6b04f7
25 of 43 declarations
Acerca de Panacea Biotec Limited
Panacea Biotec Limited es una empresa enfocada en el sector de la salud y farmacéutico, que ofrece soluciones biofarmacéuticas innovadoras. Cotiza en la XBOM.